TY - JOUR
T1 - Effectiveness of an innovative treatment protocol for misophonia in children and adolescents
T2 - Design of a randomized controlled trial
AU - Rappoldt, L.R.
AU - van der Pol, M.M.
AU - de Wit, C.
AU - Slaghekke, S.
AU - Houben, C.
AU - Sondaar, T.
AU - Kan, K.J.
AU - van Steensel, F.J.A.
AU - Denys, D.
AU - Vulink, N.C.C.
AU - Utens, E.M.W.J.
N1 - Funding Information: We gratefully acknowledge Fonds Stichting Gezondheidszorg Spaarneland, the Netherlands, for funding this research project, and the involved children, parents and teachers for participating in this study. Furthermore, we want to thank the Dutch patient organization Vereniging Misofonie NL, specifically chair Tom Sondaar, as well as the involved therapists, for the pleasant collaboration. Lastly, we gratefully acknowledge Benjamin Tros for language editing. Funding Information: This research project is funded by Fonds Stichting Gezondheidszorg Spaarneland (Grand ID: 2020353 ). The funding source had no role in the design of the study, and will not have any role in its execution, analysis, interpretation of the data, or decision to submit results. Publisher Copyright: © 2023 The Authors
PY - 2023/6/1
Y1 - 2023/6/1
N2 - Background: Misophonia is a recently identified disorder in which individuals experience intense, uncontrollable and disproportional irritation, anger or disgust when confronted with specific sounds or stimuli associated with these sounds. Prevalence rates in children and adolescents are currently still to be investigated. The reported average age of onset is around 13 years, in clinical practice children from 8 years old are referred. Misophonia is associated with avoidance and anticipation anxiety, possibly leading to serious educational and social consequences for children and families. Worldwide, no evidence-based treatment exists specifically for children and adolescents with misophonia. This article presents the design of a randomized controlled trial testing the effectiveness of cognitive behavioral therapy (CBT) combined with psychomotor therapy (PMT) for misophonia in children and adolescents (aged 8–18). Methods: In total, 82 patients will be randomly assigned to a treatment condition or waiting list condition of 3 months (WCG). Treatment consists of 7 weekly group therapy sessions (1.5 h CBT plus 1.5 h PMT) and a follow-up after 3 weeks. Pre and post treatment assessments will be conducted during a baseline assessment, after 3 and 6 months. The primary outcome will be assessed by the Amsterdam Misophonia Scale – Youth (AMISOS-Y) and secondary outcomes (e.g. quality of life) and putative predictors (e.g. parenting burden) will be studied. Conclusion: This trial is the first study worldwide testing the effectiveness of a combined CBT plus PMT protocol for misophonia in children and adolescents. If proven effective, this protocol provides an innovation to improve care for youth with misophonia.
AB - Background: Misophonia is a recently identified disorder in which individuals experience intense, uncontrollable and disproportional irritation, anger or disgust when confronted with specific sounds or stimuli associated with these sounds. Prevalence rates in children and adolescents are currently still to be investigated. The reported average age of onset is around 13 years, in clinical practice children from 8 years old are referred. Misophonia is associated with avoidance and anticipation anxiety, possibly leading to serious educational and social consequences for children and families. Worldwide, no evidence-based treatment exists specifically for children and adolescents with misophonia. This article presents the design of a randomized controlled trial testing the effectiveness of cognitive behavioral therapy (CBT) combined with psychomotor therapy (PMT) for misophonia in children and adolescents (aged 8–18). Methods: In total, 82 patients will be randomly assigned to a treatment condition or waiting list condition of 3 months (WCG). Treatment consists of 7 weekly group therapy sessions (1.5 h CBT plus 1.5 h PMT) and a follow-up after 3 weeks. Pre and post treatment assessments will be conducted during a baseline assessment, after 3 and 6 months. The primary outcome will be assessed by the Amsterdam Misophonia Scale – Youth (AMISOS-Y) and secondary outcomes (e.g. quality of life) and putative predictors (e.g. parenting burden) will be studied. Conclusion: This trial is the first study worldwide testing the effectiveness of a combined CBT plus PMT protocol for misophonia in children and adolescents. If proven effective, this protocol provides an innovation to improve care for youth with misophonia.
KW - Adolescents
KW - Children
KW - Cognitive behavioral therapy
KW - Misophonia
KW - Psychomotor therapy
UR - http://www.scopus.com/inward/record.url?scp=85150346600&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.conctc.2023.101105
DO - https://doi.org/10.1016/j.conctc.2023.101105
M3 - Article
C2 - 36950304
SN - 2451-8654
VL - 33
JO - Contemporary Clinical Trials Communications
JF - Contemporary Clinical Trials Communications
M1 - 101105
ER -